This inventor holds 3 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2025
Title: Gema Ruano Plaza: Innovator in Pharmaceutical Science
Introduction
Gema Ruano Plaza is an accomplished inventor based in Madrid, Spain, renowned for her contributions to pharmaceutical sciences. With two patents to her name, she has made significant strides in the field of medicinal chemistry, particularly regarding Ghrelin O-acyl transferase inhibitors.
Latest Patents
Gema's latest innovations include two closely related patents focused on Ghrelin O-acyl transferase inhibitors. The first patent presents novel GOAT inhibitors and their salts, along with pharmaceutical compositions thereof. The second patent reiterates this innovation, reinforcing the potential therapeutic applications of these inhibitors in treating various health conditions.
Career Highlights
Gema is currently employed at Eli Lilly and Company, a leading global pharmaceutical company dedicated to creating innovative medicines. Her work there highlights her commitment to enhancing drug development processes and cultivating innovative solutions in healthcare.
Collaborations
Throughout her career, Gema has collaborated with notable professionals, including Christopher Stanley Galka and Erik James Hembre, II. These partnerships exemplify the collaborative spirit driving innovation in the pharmaceutical industry.
Conclusion
Gema Ruano Plaza's dedication to her research and her impressive patent portfolio positions her as a prominent figure in pharmaceutical innovation. Her work continues to inspire future advancements and contributes to improving healthcare solutions worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile